96 related articles for article (PubMed ID: 23719523)
1. [Effect of adaptive replanning on adverse reactions and clinical outcome in nasopharyngeal carcinoma treated by helical tomotherapy].
Yao W; DU L; Ma L; Feng L; Cai B; Xu S; Xie C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 May; 38(5):468-75. PubMed ID: 23719523
[TBL] [Abstract][Full Text] [Related]
2. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.
Luo Y; Qin Y; Lang J
Clin Transl Oncol; 2017 Apr; 19(4):470-476. PubMed ID: 27718153
[TBL] [Abstract][Full Text] [Related]
3. The role of replanning in fractionated intensity modulated radiotherapy for nasopharyngeal carcinoma.
Zhao L; Wan Q; Zhou Y; Deng X; Xie C; Wu S
Radiother Oncol; 2011 Jan; 98(1):23-7. PubMed ID: 21040992
[TBL] [Abstract][Full Text] [Related]
4. Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma.
Yang H; Hu W; Wang W; Chen P; Ding W; Luo W
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e47-54. PubMed ID: 23122981
[TBL] [Abstract][Full Text] [Related]
5. Propensity score matching analysis of a phase II study on simultaneous modulated accelerated radiation therapy using helical tomotherapy for nasopharyngeal carcinomas.
Du L; Zhang XX; Feng LC; Qu BL; Chen J; Yang J; Liu HX; Xu SP; Xie CB; Ma L
BMC Cancer; 2017 Aug; 17(1):582. PubMed ID: 28851315
[TBL] [Abstract][Full Text] [Related]
6. Clinical observation of 73 nasopharyngeal carcinoma patients treated by helical tomotherapy: the China experience.
Ren G; Du L; Ma L; Feng LC; Zhou GX; Qu BL; Xu SP; Xie CB; Ou GM; Li F; Zhang XX; Yang J
Technol Cancer Res Treat; 2011 Jun; 10(3):259-66. PubMed ID: 21517132
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and toxicity of helical tomotherapy for patients with locally recurrent nasopharyngeal carcinoma.
Puebla F; Lopez Guerra JL; Garcia Ramirez JM; Matute R; Marrone I; Miguez C; Sevillano D; Sanchez-Reyes A; Rivin Del Campo E; Praena-Fernandez JM; Azinovic I
Clin Transl Oncol; 2015 Nov; 17(11):925-31. PubMed ID: 26108408
[TBL] [Abstract][Full Text] [Related]
8. Clinical Outcome and Prognostic Factors of Intensity-Modulated Radiotherapy for T4 Stage Nasopharyngeal Carcinoma.
Luo Y; Gao Y; Yang G; Lang J
Biomed Res Int; 2016; 2016():4398498. PubMed ID: 27195286
[TBL] [Abstract][Full Text] [Related]
9. Clinical Outcomes of Several IMRT Techniques for Patients With Head and Neck Cancer: A Propensity Score-Weighted Analysis.
Bibault JE; Dussart S; Pommier P; Morelle M; Huguet M; Boisselier P; Coche-Dequeant B; Alfonsi M; Bardet E; Rives M; Calugaru V; Chajon E; Noel G; Mecellem H; Servagi Vernat S; Perrier L; Giraud P
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):929-937. PubMed ID: 28864403
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning.
Chen AM; Daly ME; Cui J; Mathai M; Benedict S; Purdy JA
Head Neck; 2014 Nov; 36(11):1541-6. PubMed ID: 23996502
[TBL] [Abstract][Full Text] [Related]
11. Clinical Outcomes of Nasopharyngeal Carcinoma Patients Treated with Adaptive Helical Tomotherapy, A 5-year Experience.
Arslan SA
Niger J Clin Pract; 2020 Dec; 23(12):1683-1689. PubMed ID: 33355821
[TBL] [Abstract][Full Text] [Related]
12. Predictors for replanning in loco-regionally advanced nasopharyngeal carcinoma patients undergoing intensity-modulated radiation therapy: a prospective observational study.
Yan D; Yan S; Wang Q; Liao X; Lu Z; Wang Y
BMC Cancer; 2013 Nov; 13():548. PubMed ID: 24237861
[TBL] [Abstract][Full Text] [Related]
13. Clinical study of nasopharyngeal carcinoma treated by helical tomotherapy in China: 5-year outcomes.
Du L; Zhang XX; Ma L; Feng LC; Li F; Zhou GX; Qu BL; Xu SP; Xie CB; Yang J
Biomed Res Int; 2014; 2014():980767. PubMed ID: 25114932
[TBL] [Abstract][Full Text] [Related]
14. Advances and challenges in intensity-modulated radiotherapy for nasopharyngeal carcinoma.
Qu S; Liang ZG; Zhu XD
Asian Pac J Cancer Prev; 2015; 16(5):1687-92. PubMed ID: 25773811
[TBL] [Abstract][Full Text] [Related]
15. Clinical Outcomes of Volume-Modulated Arc Therapy in 205 Patients with Nasopharyngeal Carcinoma: An Analysis of Survival and Treatment Toxicities.
Guo R; Tang LL; Mao YP; Zhou GQ; Qi ZY; Liu LZ; Lin AH; Liu MZ; Ma J; Sun Y
PLoS One; 2015; 10(7):e0129679. PubMed ID: 26146828
[TBL] [Abstract][Full Text] [Related]
16. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.
Su SF; Han F; Zhao C; Chen CY; Xiao WW; Li JX; Lu TX
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):327-33. PubMed ID: 21035959
[TBL] [Abstract][Full Text] [Related]
18. Clinical study on the changes of the tumor target volume and organs at risk in helical tomotherapy for nasopharyngeal carcinoma.
Lu N; Feng LC; Cai BN; Hou J; Wang YL; Xie CB
Chin Med J (Engl); 2012 Jan; 125(1):87-90. PubMed ID: 22340471
[TBL] [Abstract][Full Text] [Related]
19. Actual anatomical and dosimetric changes of parotid glands in nasopharyngeal carcinoma patients during intensity modulated radiation therapy.
Ren G; Xu SP; Du L; Feng LC; Qu BL; Liu HX; Xie CB; Ma L
Biomed Res Int; 2015; 2015():670327. PubMed ID: 25793202
[TBL] [Abstract][Full Text] [Related]
20. Clinical study of the necessity of replanning before the 25th fraction during the course of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.
Wang W; Yang H; Hu W; Shan G; Ding W; Yu C; Wang B; Wang X; Xu Q
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):617-21. PubMed ID: 20138444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
